Addex Announces Filing of Registration Statement for Proposed Public Offering of Securities

Addex Reports Q3 2020 Financial Results and Provides Corporate Update

Addex Receives Additional $2.8 million from Indivior and Extends GABAB PAM Research Collaboration

Addex to Report Q3 Financial Results and host Conference Call on November 3, 2020

Addex to Present at the Investora Conference

Addex Therapeutics to Participate at the H.C. Wainwright 22nd Annual Global Investment Conference

Addex Therapeutics to Participate at the Biotechgate Digital Partnering Conference

Addex and the SIB Swiss Institute of Bioinformatics Receive Innosuisse Grant to Repurpose Potent Dopamine Antagonist Using Computational Modelling

Addex Reports 2020 Half-Year Financial Results and Provides Corporate Update

ADDEX THERAPEUTICS TO RELEASE HALF-YEAR 2020 FINANCIAL RESULTS AND HOST CONFERENCE CALL ON AUGUST 12, 2020